Tradestie Institutional Equity Comparison Engine

NMR vs CRCL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NMR Overall Edge

NMR Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nomura Holdings, Inc (NMR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NMR trades at 12.7x Forward P/E with 25.1% operating margin (+17.9% YoY revenue) versus CRCL at 44.5x Forward P/E and 11.3% operating margin (+16.9% YoY). In options structure, NMR sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against CRCL sits in BREAKDOWN (86th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NMR
NMR 12.7x vs CRCL 44.5x Fwd P/E
Growth & Margin Winner NMR
Op Margin 25.1% vs 11.3% ยท YoY +17.9% vs +16.9%
Momentum & Technical Winner NMR
1Y +26.3% vs -33.1% ยท 52W Pos 60% vs 5%
Options & Structure Winner NMR
UNCLASSIFIED (<1st %ile IV) vs BREAKDOWN (86th %ile IV)
NMR NYSE
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap $28.3B
1M Return +2.36%
1Y Return +26.32%
Forward P/E 12.7x
Unified AI Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
CRCL NYSE
Circle Internet Group, Inc.
Finance Services
$54.80
-4.94% 1D
Market Cap $16.0B
1M Return -32.65%
1Y Return -33.08%
Forward P/E 44.5x
Unified AI Score
42.6 / 100 HOLD
Tech 25.0 Fund 44.0 Flow 57.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NMR +26.32% CRCL -33.08% Spread: +59.4 pp (NMR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NMR TTM Op. Margin: 25.1% CRCL TTM Op. Margin: 11.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs CRCL. Trailing 12-month operating profitability (NMR 25.1% vs CRCL 11.3%) and valuation multiples (NMR 12.7x vs CRCL 44.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NMR (9) vs CRCL (1)
Institutional Metric NMR CRCL Criterion Row Winner
Market Capitalization Scale $28.3B $16.0B Larger Scale NMR
Trailing P/E Ratio Valuation 11.2x 37.5x Lower Multiple NMR
Forward P/E Ratio Valuation 12.7x 44.5x Lower Multiple NMR
Revenue Growth (YoY) Growth +17.9% +16.9% Higher Growth NMR
Operating Margin (TTM) Profitability 25.1% 11.3% Higher Margin NMR
Net Profit Margin Profitability 17.1% 15.3% Higher Margin NMR
Return on Equity (ROE) Capital Efficiency 11.5% 13.4% Higher ROE CRCL
52-Week Range Position Momentum 60% ($7โ€“$11) 5% ($50โ€“$140) Stronger Trend NMR
Beta / 30D Volatility Risk Regime 1.03ฮฒ ยท 29% Vol 2.45ฮฒ ยท 67% Vol Lower Realized Risk NMR
Unified Institutional Score Composite Signal 44.5 / 100 (HOLD) 42.6 / 100 (HOLD) Higher Composite NMR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NMR vs CRCL Buy Guide
NMR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live NMR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CRCL BREAKDOWN
52d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 86th %ile
IV Regime Extreme (>80th %ile)
Live CRCL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NMR nor CRCL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.